Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5543 Target Snapshot

Dual specificity tyrosine-phosphorylation-regulated kinase 1B · SINGLE PROTEIN · Homo sapiens

2,233Compounds
391Assays
10Approved Drugs
1,687.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9Y463. Use UniProt Q9Y463 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9Y463 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dual specificity tyrosine-phosphorylation-regulated kinase 1B as ChEMBL target CHEMBL5543, mapped to UniProt Q9Y463. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dual specificity tyrosine-phosphorylation-regulated kinase 1B
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5543
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9Y463
Dual specificity tyrosine-phosphorylation-regulated kinase 1B
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dual specificity tyrosine-phosphorylation-regulated kinase 1B is the right protein anchor across sources, using UniProt Q9Y463 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDual specificity tyrosine-phosphorylation-regulated kinase 1B
UniProt AccessionQ9Y463
Component TypeProtein
Sequence Length629 aa

Dual specificity tyrosine-phosphorylation-regulated kinase 1B

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dual specificity tyrosine-phosphorylation-regulated kinase 1B, mapped to UniProt Q9Y463. Sequence length is 629 aa.

Mapped IDQ9Y463
Review nameDual specificity tyrosine-phosphorylation-regulated kinase 1B
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

10
Approved
8
Phase III
11
Phase II
10
Phase I
Assay Mix

Activity Type Distribution

IC501,099.0
KI393.0
KD195.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5093650 10.3 Kd 0.05 Preclinical
CHEMBL2386744 9.62 IC50 0.24 Preclinical
CHEMBL2386770 9.62 IC50 0.24 Preclinical
CHEMBL2386747 9.55 IC50 0.28 Preclinical
CHEMBL2386745 9.23 IC50 0.59 Preclinical
CHEMBL3894571 9.23 IC50 0.59 Preclinical
CHEMBL1965660 9.2 Ki 0.631 Preclinical
CHEMBL388978 9.02 IC50 0.967 Preclinical
CHEMBL5082044 9.0 IC50 1.0 Preclinical
CHEMBL5083159 9.0 IC50 1.0 Preclinical
Distribution

pChEMBL Value Distribution

68
5.0
169
5.5
191
6.0
197
6.5
188
7.0
117
7.5
109
8.0
35
8.5
19
9.0
7
9.5
pChEMBL
Approved Drugs

Approved Drugs

ABEMACICLIB
CHEMBL3301610
Approved 2017
NIRAPARIB
CHEMBL1094636
Approved 2017
MIDOSTAURIN
CHEMBL608533
Approved 2017
RUCAPARIB
CHEMBL1173055
Approved 2016
PALBOCICLIB
CHEMBL189963
Approved 2015
Assay Landscape

Assay Landscape

391
Total Assays
824
Tested Compounds
3
Assay Types
Binding — 381 assays, 824 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 279 571 7.0
assay format 79 149 6.5
cell-based format 17 103 6.9
tissue-based format 5 0
subcellular format 1 1 5.9
ADME — 5 assays, 13 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 4 13 6.8
single protein format 1 0
Functional — 5 assays, 204 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 1 5.9
assay format 2 203 5.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine